Spis treści:
Spis załączników:
Sopharma_monthly_March_2013.doc (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
Sopharma_monthly_March_2013.doc (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 43 | / | 2013 | ||||||||
| Date of issue: | 2013-04-04 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma monthly March 2013 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne |
|||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") notifies that for March 2013 Sopharma AD realized a decrease of sales revenues of 10% compared to the same period of 2012, including 12% increase of domestic sales and 20% decrease of export sales. During the past three months Sopharma AD recorded a decrease of sales revenues of 4%, including 5% increase of domestic sales and 8% decrease of export sales compared to 2012. |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Sopharma monthly March 2013.docSopharma monthly March 2013.doc | Sopharma monthly March 2013 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-04-04 | Ognian Donev | Executive Director | |||